Abstract
The past several years have witnessed a major surge of interest in the cardiovascular actions of insulin and the potential role played by both the sympathetic nervous system and the l-arginine nitric oxide system in the mediation of these actions.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Abramson DI, Schkloven N, Margolis MN, Mirsky IA (1939) Influence of massive doses of insulin on peripheral blood flow in man. Am J Physiol 128: 124–132
Acheson K, Jéquier E, Wahren J (1983) Influence of beta-adrenergic blockade on glucose-induced thermogenesis in man. J Clin Invest 72: 981–986
Anderson EA, Hoffman RP, Balon TW, Sinkey CA, Mark AL (1991) Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans. J Clin Invest 87: 2246–2252
Andersson B, Elam M, Wallin BG, Björntop P, Andersson OK (1991) Effect of energy-restricted diet on sympathetic muscle nerve activity in obese woman. Hypertension 18: 783–789
Andres M, Baltzan MA, Cader G, Zierler KL (1961) Effect of insulin on carbohydrate metabolism and on potassium in the forearm in man. J Clin Invest 41: 108–115
Baron AD (1993) Cardiovascular actions of insulin in humans. Implications for insulin sensitivity and vascular tone. Baillieres Clin Endocrinol Metab 7: 961–987
Baron AD, Brechtel-Hook G, Johnson A, Hardin D (1993) Skeletal muscle blood flow: a possible link between insulin resistance and blood pressure. Hypertension 21: 129–135
Bennet WM, Connacher AA, Scrimgeour CM, Jung JT, Rennie MJ (1990) Euglycemic hyperinsulinemia augments amino acid uptake by human leg tissues during hyperaminoacidemia. Am J Physiol 259: E185 - E194
Berne C, Fagius J, Pollare T, Hjemdahl P (1992) The sympathetic response to euglycaemic hyperinsulinaemia: evidence from microelectrode nerve recordings in healthy subjects. Diabetologia 35: 873–879
Bevan RD (1984) Trophic effects of peripheral adrenergic nerves on vascular structure. Hypertension 6 [Suppl III]: 11119–11126
Bonora E, Zavaroni I, Alpi O, Pezzarossa A, Bruschi F, Dall’Aglio E, Guerrra L, Coscelli C, Butturini U (1987) Relationship between blood pressure and plasma insulin in non-obese and obese non-diabetic subjects. Diabetologia 30: 719–723
Brown MR, Fisher LA (1985) Corticotropin-releasing factor: effects on the autonomic nervous system and visceral systems. Fed Proc 44: 243–248
Calver A, Collier J, Vallance P (1992) Inhibition and stimulation of nitric oxide synthesis in the human forearm arterial bed of patients with insulin-dependent diabetes. J Clin Invest 90: 2548–2554
Chrisholm DJ, Klassen GA, Dupre J, Pozefski T (1975) Interaction of secretin and insulin on human forearm metabolism. Eur J Clin Invest 5: 487–494
Christin L, O’Connell M, Bogardus C, Danforth E, Ravussin E (1993) Norepinephrine turnover and energy expenditure in Pima Indian and white men. Metabolism 42: 723–729
Clayton S, Cross M (1963) The aggregation of blood platelets by catecholamines and by thrombin. J Physiol (Lond) 169: 82 P
Daly PA, Landsberg L (1991) Hypertension in obesity and NIDDM. Diabetes Care 14: 240–248
Davisson RL, Hogue AM, Johnson AK, Lewis SJ (1993) Sympathetic vasodilator neurons innervating rat hindlimb vasculature may release nitrosyl factors. Hypertension 22: 413
DeFronzo RA, Tobin JD, Andres R (1979) Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237: E214 - E223
DiSalvo RJ, Bloom WL, Brust AA, Ferguson RW, Ferris EB (1956) A comparison of the metabolic and circulatory effects of epinephrine, norepinephrine and insulin hypoglycemia with observations on the influence of autonomic blocking agents. J Clin Invest 35: 568–577
Dustan HP (1991) Obesity and hypertension. Diabetes Care 14: 488–504
Felber JP, Haesler E, Jéquier E (1993) Metabolic origin of insulin resistance in obesity with and without Type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 36: 1221–1229
Ferrannini E, Buzzigogli RD, Bonadonna R, Giorico MA, Oleggini M, Graziadei L, Pedrinelli R, Brandi L, Bevilaqua S (1987) Insulin resistance in essential hypertension. N Engi J Med 317: 350–357
Ferrannini E, Taddei S, Santoro D, Natali A, Boni C, Del Chiaro D, Buzzigoli G (1988) Independent stimulation of glucose metabolism and Na-K exchange by insulin in the human forearm. Am J Physiol 255: E953 - E958
Gelfand RA, Barret EJ (1987) Effect of physiological hyperinsulinemia on skeletal muscle protein synthesis and breakdown in man. J Clin Invest 8o: 1–6
Ginsburg J, Paton A (1956) Effects of insulin after adrenalectomy. Lancet 271: 491–494
Gordon T, Kannel WB (1976) Obesity and cardiovascular disease: the Framingham study. Clin Endocrinol Metab 5: 367–375
Gosink PD, Chauvez M, Green PK, Woods SC, Figlewicz DP, Wilkinson CW, Baskin DG, Schwartz MW (1992) Central insulin administration lowers body weight via a glucocorticoid sensitive mechanism. Clin Res 40: 55A
Gruber KA, Callahan MF (1989) ACTH-(4-lo) through gamma-MSH: evidence for a new class of central autonomic system-regulating peptides. Am J Physiol 257: R681 - R694
Hohnloser J, Von Werder K, Müller OA (1989) Acute dexamethasone suppression of ACTH secretion stimulated by human corticotrophin releasing hormone. Clin Endocrinol (Oxf) 31: 175–184
Holt S, York DA, Fitzsimons JTR (1983) The effect of corticosterone, cold exposure and overfeeding with sucrose on brown adipose tissue of obese Zucker rats (fa/fa). Biochem J 214: 215–223
Hwang IS, Ho H, Hoffman BB, Reaven GM (1987) Fructose-induced insulin resistance and hypertension in rats. Hypertension 14: 117–119
Jacobs DB, Sowers JR, Hmeidan A, Niyogi T, Simpson L, Standley PR (1993) Effects of weight reduction on cellular cation metabolism and vascular resistance. Hypertension 21: 308–314
Kurosawa M, Sato A, Swenson R, Takahashi Y (1985) Sympatho-adrenal medullary functions in response to intracerebroventricular injected corticotropin-releasing factor in anesthetized rats. Brain Res 367: 250–257
Laakso M, Edelman SV, Brechtel G, Baron AD (1990a) Decreased effect of insulin to stimulate muscle blood flow in obese man. A novel mechanism for insulin resistance. J Clin Invest 85: 1844–1852
Laakso M, Edelman SV, Olefsky JM, Brechtel G, Wallace P, Baron AD (1990b) Kinetics of in vivo muscle insulin-mediated glucose uptake in human obesity. Diabetes 39: 965–974
Laakso M, Edelman SV, Brechtel G, Baron AD (1992a) Impaired insulin-mediated skeletal muscle blood flow in patients with NIDDM. Diabetes 41: 1076–1083
Laakso M, Edelman SV, Brechtel G, Baron AD (1992b) Effects of epinephrine on insulin-mediated glucose uptake in whole body and leg muscle in humans: role of blood flow. Am J Physiol 263: E199 - E204
Landsberg L (1986) Diet, obesity and hypertension: a hypothesis involving insulin, the sympathetic nervous system and adaptive thermogenesis. Q J Med 236: 1081–1090
Lembo G, Napoli R, Capaldo B, Rendina V, Iaccarino G, Volpe M, Trimarco B, Sacca L (1992) Abnormal sympathetic overactivity evoked by insulin in skeletal muscle of patients with essential hypertension. J Clin Invest 90: 24–29
Levy RL, White PD, Stroud WD, Hillman CC (1946) Overweight: prognostic significance in relation to hypertension and cardiovascular disease. JAMA 131: 951–953
Liang C-S, Doherty JU, Faillace R, Maekawa K, Arnold S, Gavras H, Hood WB (1982) Insulin infusion in conscious dogs: effects on systemic and coronary hemodynamics, regional blood flows, and plasma catecholamines. J Clin Invest 69: 1321–1336
Lillioja S, Young AA, Cuiter CL, Ivy JL, Abbot WGH, Zawadski JK, Yki-Järvinen H, Christin L, Secomb TW, Bogardus C (1987) Skeletal muscle capillary density and fiber type are possible determinants of in vivo insulin resistance in man. J Clin Invest 1987: 415–425
Lucas CP, Estigarribia JA, Darga LL, Reaven GM (1985) Insulin and blood pressure in obesity. Hypertension 7: 702–706
Margolis RU, Altszuler N (1967) Insulin in the cerebrovascular fluid. Nature 215: 1375–1376
Modan M, Halkin H (1991) Hyperinsulinemia or increased sympathetic drive as links for obesity and hypertension. Diabetes Care 14: 470–487
Modan M, Halkin H, Almog S, Lusky A, Eshkol A, Shefi M, Shitrit A, Fuchs Z (1985) Hyperinsulinemia. A link between hypertension, obesity, and glucose intolerance. J Clin Invest 75: 809–817
Morgan DA, Balon TW, Mark AL (1991) High fructose diet promotes exaggerated sympathetic and pressor responses to hyperinsulinemia in rats. FASEB J 5: A1497
Morgan DA, Balon TW, Ginsberg BH, Mark AL (1993) Nonuniform regional sympathetic nerve responses to hyperinsulinemia in rats. Am J Physiol 264: R423 - R427
Muller JE, Tofler GH, Stone PH (1989) Circadian variation and triggers of onset of acute cardiovascular disease. Circulation 80: 267–275
Natali A, Buzzigoli G, Taddei S, Santoro D, Cerri M, Pedrinelli R, Ferrannini E (1990) Effects of insulin on hemodynamics and metabolism in the human forearm. Diabetes 39: 490–500
Overton JM, Fischer LA (1989) Central nervous system actions of corticotropin-releasing factor on cardiovascular function in the absence of locomotor activity. Regul Pept 25: 315–324
Pereda SA, Eckstein JW, Abboud FM (1962) Cardiovascular responses to insulin in the absence of hypoglycemia. Am J Physiol 202: 249–252
Randin D, Vollenweider P, Tappy L, Jéquier E, Nicod P, Scherrer U (1994) Effects of adrenergic and cholinergic blockade on insulin-induced stimulation of calf blood flow in humans. Am J Physiol 266: R809 - R816
Randin D, Vollenweider P, Tappy L, Jéquier E, Nicod P, Scherrer U (1995) Suppression of alcohol-induced sympathetic activation and elevation of arterial pressure by dexamethasone. N Engl J Med 332 (in press)
Randle PJ, Garland PB, Hales CN, Newsholme EA (1963) The glucose fatty-acid cycle: its role in insulin sensitivity and metabolic disturbances of diabetes mellitus. Lancet 1: 785–789
Reaven GM (1988) Role of insulin resistance in human disease. Diabetes 37: 1595–1607
Richter EA, Mikines KJ, Galbo H, Kiens B (1989) Effect of exercise on insulin action in human skeletal muscle. J Appl Physiol 66: 876–885
Rowe JW, Young JB, Minaker KL, Stevens AL, Pallota J, Landsberg L (1981) Effects of insulin and glu- cose infusions on sympathetic nervous system activity in normal man. Diabetes 30: 219–225
Saenz de Tejada I, Goldstein I, Azadzoi K, Krane RJ, Cohen RA (1989) Impaired neurogenic and endothelium-mediated relaxation of penile smooth muscle from diabetic men with impotence. N Engl J Med 320: 1025–1030
Sauter A, Goldstein M, Engel J, Ueta K (1983) Effect of insulin on central catecholamines. Brain Res 260: 330–333
Scherrer U, Vissing SF, Morgan BJ, Rollins JA, Tindall RSA, Ring S, Hanson P, Mohanty PK, Victor RG (1990) Cyclosporine-induced sympathetic activation and hypertension after heart transplantation. N Engl J Med 323: 693–699
Scherrer U, Vollenweider P, Randin D, Jéquier E, Nicod P, Tappy L (1993) Suppression of insulin induced sympathetic activation and vasodilation by dexamethasone in humans. Circulation 88: 388–394
Scherrer U, Randin D, Tappy L, Vollenweider P, Jéquier E, Nicod P (1994a) Body fat and sympathetic nerve activity in healthy subjects. Circulation 89: 2634–2640
Scherrer U, Randin D, Vollenweider P, Vollenweider L, Nicod P (1994b) Nitric oxide release accounts for insulin’s vascular effects in humans. J Clin Invest 94: 2511–2515
Schwartz MW, Figlewicz DP, Baskin DG, Woods SC, Porte DJ (1992) Insulin in the brain: a hormonal regulator of energy balance. Endocr Rev 13: 387–414
Scott NA, Webb V, Boublik JH, Rivier J, Brown MR (1989) The cardiovascular actions of centrally administered neuropeptide Y. Regul Pept 25: 247–258
Shen DC, Shieh SM, Fuh MT, Wu DA, Chen YDI, Reaven GM (1988) Resistance to insulin-stimulated glucose uptake in patients with hypertension. J Clin Endocrinol Metab 66: 580–583
Shepherd JT (1990) Increased systemic vascular resistance and primary hypertension: the expanding complexity. J Hypertens 8 [Suppl 7]: 515–527
Shepherd JT, Vanhoutte PM (1979) Interactions between cardiovascular and endocrine control. In: Shepherd JT, Vanhoutte PM (eds) The human cardiovascular system. Facts and concepts. Raven, New York, p 153
Sloan JA, Hooper M, Izzo JL Jr (1989) Effects of circulating norepinephrine on platelets, leukocyte and RBC counts by alphas-adrenergic stimulation. Am J Cardiol 63: 1140–1142
Spraul M, Ravussin E, Fontvieille AM, Rising R, Larson DE, Anderson EA (1993) Reduced sympathetic nerve activity. A potential mechanism predisposing to body weight gain. J Clin Invest 92: 1730–1735
Steinberg HO, Brechtel G, Johnson A, Fineberg N, Baron AD (1994) Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release. J Clin Invest 94: 1172–1179
Tagawa T, Imaizumi T, Endo T, Shiramoto M, Hirooka Y, Ando S, Takeshita A (1993) Vasodilatory effect of arginine vasopressin is mediated by nitric oxide in human forearm vessels. J Clin Invest 92: 1483–1490
Takeshita AT, Mark AL (1980) Decreased vasodilator capacity of forearm resistance vessels in borderline hypertension. Hypertension 2: 610–616
Valiance P, Collier J, Moncada S (1989) Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet ii: 997–1000
Vallbo AB, Hagbarth KE, Torebjörk HE, Wallin BG (1979) Somatosensory, proprioceptive, and sympathetic activity in human peripheral nerves. Physiol Rev 59: 919–957
Van Houten M, Posner BI (1979) Insulin binds to brain blood vessels. Nature 282: 623–625
Victor RG, Leimbach WN, Seals DR, Wallin BG, Mark AL (1987) Effects of the cold pressure test on muscle sympathetic nerve activity in humans. Hypertension 9: 429–436
Vollenweider P, Tappy L, Randin D, Schneiter P, Jéquier E, Nicod P, Scherrer U (1993) Differential effects of hyperinsulinemia and carbohydrate metabolism on sympathetic nerve activity and muscle blood flow in humans. J Clin Invest 92: 147–154
Vollenweider P, Randin D, Tappy L, Jéquier E, Nicod P, Scherrer U (1994) Impaired insulin-induced sympathetic neural activation and vasodilation in skeletal muscle in obese humans. J Clin Invest 93: 2365–2371
Vollenweider L, Tappy L, Owlya R, Jéquier E, Nicod P, Scherrer U (1995) Insulin-induced sympathetic activation and vasodilation in skeletal muscle. Effects of insulin resistance in lean subjects. Diabetes 44 (in press)
Yang YI, Hope ID, Ader M, Bergman RN (1989) Insulin transport across capillaries is rate limiting for insulin action in dogs. J Clin Invest 84: 1620–1628
Young JB, Landsberg L (1977) Stimulation of the sympathetic nervous system during sucrose feeding. Nature 269: 615–617
Young JB, Saville E, Rothwell NJ, Stock MJ, Landsberg L (1982) Effect of diet and cold exposure on norepinephrine turnover in brown adipose tissue in the rat. J Clin Invest 69: 1061–1071
Young JB, Macdonald IA (1992) Sympathoadrenal activity in human obesity: heterogeneity of findings since 1980. Int J Obes 16: 959–967
Zurlo F, Larson K, Bogardus C, Ravussin E (1990) Skeletal muscle metabolism is a major determinant of resting energy expenditure. J Clin Invest 86: 1423–1427
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1995 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Scherrer, U. (1995). Insulin and the Regulation of the Cardiovascular System: Role of the l-arginine Nitric Oxide Pathway and the Sympathetic Nervous System. In: Lüscher, T.F. (eds) The Endothelium in Cardiovascular Disease. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-79803-0_10
Download citation
DOI: https://doi.org/10.1007/978-3-642-79803-0_10
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-79805-4
Online ISBN: 978-3-642-79803-0
eBook Packages: Springer Book Archive